Adar1-Capital-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "JWN",
  "MRUS",
  "AKRO",
  "KNSA",
  "ASND",
  "EWTX",
  "CNTA",
  "NKTR",
  "INSM",
  "RVMD",
  "TIL",
  "ARGX",
  "AQN",
  "EXAS",
  "MDGL",
  "APLS",
  "ARWR",
  "PTCT",
  null,
  null,
  null,
  "IROH",
  null,
  null,
  null,
  null,
  null,
  null,
  "ABVX",
  null,
  "DVAX",
  "MREO",
  "RGNX",
  "RXRX",
  "SWTX",
  "RCKT",
  "ARVN",
  "ATXS",
  "TNGX",
  "GPCR",
  "SLN",
  "SVRA",
  "THRD",
  "TSHA",
  "ACHV",
  "NRIX",
  "STOK",
  "SMMT",
  "TECX",
  "MLYS",
  "KYMR",
  "PHAT",
  "NMRA",
  "KROS",
  "ADGM",
  "ABOS",
  "NGNE",
  "SAGE",
  "ALEC",
  "ALDX",
  "AVTX",
  "AMLX",
  "JANX",
  "AVR",
  "BIOA",
  "PHGE",
  "BOLT",
  "CLRB",
  null,
  null,
  "CTNM",
  "ESTA",
  "GERN",
  "SRRK",
  "FULC",
  "SYRE",
  "APGE",
  "ISRG",
  "ABUS",
  null,
  null,
  "KALA",
  "KRRO",
  "KALV",
  "LPTX",
  "LXEO",
  null,
  "MNPR",
  "NXTC",
  "OABI",
  "OVID",
  "OKUR",
  "RLYB",
  "PRQR",
  "QNCX",
  "PMVP",
  "RNXT",
  "SPRO",
  "SEPN",
  "STTK",
  "SGRY",
  "IOVA",
  null,
  null,
  null,
  null,
  "IKT",
  "TARA",
  "RZLT",
  "NVS",
  "TEVA",
  null,
  "ZYME",
  "ZURA",
  null,
  null,
  "OGN",
  "PFE",
  null,
  null,
  null,
  "REGN",
  null,
  null,
  "UPB",
  "RAPT",
  "PTGX",
  "PEPG",
  "AGIO",
  "AVXL",
  null,
  "SLDB",
  "TENX",
  "LYRA",
  "RYTM",
  "MLTX",
  "SLNO",
  "ACLX",
  null,
  "ETNB",
  "DYN",
  "ARDX",
  "CKPT",
  "SPRB",
  "TXMD",
  "GOSS",
  "SRPT",
  "NTRA",
  "WVE",
  "ROIV",
  null,
  null,
  "CNTB",
  "CNTX",
  "CDTX",
  "ELDN",
  "DCTH",
  null,
  "IMNM",
  "ITOS",
  "INZY",
  "KURA",
  "KZR",
  null,
  "VRNA",
  "VTYX",
  "VTGN",
  "VKTX",
  "VIR",
  "VRDN",
  "VYNE",
  "VYGR",
  "XENE",
  "XLO",
  "ZLAB",
  "XNCR",
  "ORKA",
  "BIIB",
  "BHVN",
  null,
  "IMVT",
  null,
  "PCVX",
  "BCRX",
  "BNTX",
  "BMRN",
  "BBIO",
  "CRGX",
  "CLDX",
  "CGON",
  "CLOV",
  "CRNX",
  "DAWN",
  "CTMX",
  "CYTK",
  "DNLI",
  "DNTH",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 198
Total Value: 523731625
Accession Number: 0001940272-25-000003
Form Type: 13F-HR
CIK: adar1-capital-management
Manager Name: Adar1-Capital-Management

Data Enrichment

82% identified

163 identified35 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

198 positions • $523.7M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 10

Sort by:

Revolution Medicines, Inc.

RVMD|76155X100

Shares:177.1K

Value:$6.3M

% of Portfolio:1.2% ($6.3M/$523.7M)

Anteris Technologies Global Corp.

AVR|03675P102

Shares:1.7M

Value:$6.1M

% of Portfolio:1.2% ($6.1M/$523.7M)

G1000R101

Shares:578.4K

Value:$6.0M

% of Portfolio:1.2% ($6.0M/$523.7M)

Sage Therapeutics, Inc.

SAGE|78667J108

Shares:742.5K

Value:$5.9M

% of Portfolio:1.1% ($5.9M/$523.7M)

89bio, Inc.

ETNB|282559103

Shares:804.2K

Value:$5.8M

% of Portfolio:1.1% ($5.8M/$523.7M)

NOVARTIS AG

NVS|66987V109

Shares:50.0K

Value:$5.6M

% of Portfolio:1.1% ($5.6M/$523.7M)

19249HAB9

Shares:—

Value:$5.5M

% of Portfolio:1.0% ($5.5M/$523.7M)

G6717R120

Shares:516.5K

Value:$5.4M

% of Portfolio:1.0% ($5.4M/$523.7M)

G4444H101

Shares:469.7K

Value:$5.3M

% of Portfolio:1.0% ($5.3M/$523.7M)

Amylyx Pharmaceuticals, Inc.

AMLX|03237H101

Shares:1.5M

Value:$5.2M

% of Portfolio:1.0% ($5.2M/$523.7M)

Scholar Rock Holding Corp

SRRK|80706P103

Shares:157.1K

Value:$5.1M

% of Portfolio:1.0% ($5.1M/$523.7M)

Xenon Pharmaceuticals Inc.

XENE|98420N105

Shares:127.5K

Value:$4.3M

% of Portfolio:0.8% ($4.3M/$523.7M)

Xencor Inc

XNCR|98401F105

Shares:398.2K

Value:$4.2M

% of Portfolio:0.8% ($4.2M/$523.7M)

Mineralys Therapeutics, Inc.

MLYS|603170101

Shares:263.4K

Value:$4.2M

% of Portfolio:0.8% ($4.2M/$523.7M)

Septerna, Inc.

SEPN|81734D104

Shares:720.8K

Value:$4.2M

% of Portfolio:0.8% ($4.2M/$523.7M)

10806XAD4

Shares:—

Value:$4.0M

% of Portfolio:0.8% ($4.0M/$523.7M)

Apogee Therapeutics, Inc.

APGE|03770N101

Shares:104.9K

Value:$3.9M

% of Portfolio:0.7% ($3.9M/$523.7M)

Savara Inc

SVRA|805111101

Shares:1.4M

Value:$3.8M

% of Portfolio:0.7% ($3.8M/$523.7M)

Monopar Therapeutics

MNPR|61023L207

Shares:100.8K

Value:$3.7M

% of Portfolio:0.7% ($3.7M/$523.7M)

008064107

Shares:1.5M

Value:$3.7M

% of Portfolio:0.7% ($3.7M/$523.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Revolution Medicines, Inc.(RVMDcusip76155X100)	177.1K	QoQ +4.19% (-7.1K) YoY NEW(+177.1K)	All Managers (Combined)	$6.3M	1.2% ($6.3M/$523.7M)	QoQ -15.76% (-$1.2M) YoY NEW(+$6.3M)
Anteris Technologies Global Corp.(AVRcusip03675P102)	1.7M	QoQ +59.36% (+625.1K) YoY NEW(+1.7M)	All Managers (Combined)	$6.1M	1.2% ($6.1M/$523.7M)	QoQ +3.95% (+$232.6K) YoY NEW(+$6.1M)
(cusipG1000R101)✕	578.4K	QoQ +3.24% (+18.2K) YoY NEW(+578.4K)	All Managers (Combined)	$6.0M	1.2% ($6.0M/$523.7M)	QoQ +6.61% (+$374.3K) YoY NEW(+$6.0M)
Sage Therapeutics, Inc.(SAGEcusip78667J108)	742.5K	QoQ +3767.16% (+723.3K) YoY NEW(+742.5K)	All Managers (Combined)	$5.9M	1.1% ($5.9M/$523.7M)	QoQ +5561.86% (+$5.8M) YoY NEW(+$5.9M)
89bio, Inc.(ETNBcusip282559103)	804.2K	QoQ +56.11% (+289.1K) YoY +26181.69% (+801.2K)	All Managers (Combined)	$5.8M	1.1% ($5.8M/$523.7M)	QoQ +45.13% (+$1.8M) YoY +16314.95% (+$5.8M)
NOVARTIS AG(NVScusip66987V109)	50.0K	QoQ NEW(+50.0K) YoY NEW(+50.0K)	All Managers (Combined)	$5.6M	1.1% ($5.6M/$523.7M)	QoQ NEW(+$5.6M) YoY NEW(+$5.6M)
(cusip19249HAB9)✕	—	QoQ - YoY NEW	All Managers (Combined)	$5.5M	1.0% ($5.5M/$523.7M)	QoQ +0.12% (+$6.8K) YoY NEW(+$5.5M)
(cusipG6717R120)✕	516.5K	QoQ +3.29% (+16.5K) YoY NEW(+516.5K)	All Managers (Combined)	$5.4M	1.0% ($5.4M/$523.7M)	QoQ +6.45% (+$327.1K) YoY NEW(+$5.4M)
(cusipG4444H101)✕	469.7K	QoQ +16.22% (+65.6K) YoY +16.41% (+66.2K)	All Managers (Combined)	$5.3M	1.0% ($5.3M/$523.7M)	QoQ +25.08% (+$1.1M) YoY +26.48% (+$1.1M)
Amylyx Pharmaceuticals, Inc.(AMLXcusip03237H101)	1.5M	QoQ +14615.87% (+1.5M) YoY +4527.63% (+1.4M)	All Managers (Combined)	$5.2M	1.0% ($5.2M/$523.7M)	QoQ +13681.52% (+$5.2M) YoY +5668.24% (+$5.1M)
Scholar Rock Holding Corp(SRRKcusip80706P103)	157.1K	QoQ +705.32% (+137.6K) YoY NEW(+157.1K)	All Managers (Combined)	$5.1M	1.0% ($5.1M/$523.7M)	QoQ +499.05% (+$4.2M) YoY NEW(+$5.1M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	127.5K	QoQ +152.33% (+77.0K) YoY NEW(+127.5K)	All Managers (Combined)	$4.3M	0.8% ($4.3M/$523.7M)	QoQ +115.96% (+$2.3M) YoY NEW(+$4.3M)
Xencor Inc(XNCRcusip98401F105)	398.2K	QoQ +69.71% (-163.5K) YoY NEW(+398.2K)	All Managers (Combined)	$4.2M	0.8% ($4.2M/$523.7M)	QoQ -21.42% (-$1.2M) YoY NEW(+$4.2M)
Mineralys Therapeutics, Inc.(MLYScusip603170101)	263.4K	QoQ -68.69% (-578.1K) YoY +997.60% (+239.4K)	All Managers (Combined)	$4.2M	0.8% ($4.2M/$523.7M)	QoQ -59.61% (-$6.2M) YoY +1250.11% (+$3.9M)
Septerna, Inc.(SEPNcusip81734D104)	720.8K	QoQ NEW(+720.8K) YoY NEW(+720.8K)	All Managers (Combined)	$4.2M	0.8% ($4.2M/$523.7M)	QoQ NEW(+$4.2M) YoY NEW(+$4.2M)
(cusip10806XAD4)✕	—	QoQ - YoY NEW	All Managers (Combined)	$4.0M	0.8% ($4.0M/$523.7M)	QoQ +4.48% (+$173.3K) YoY NEW(+$4.0M)
Apogee Therapeutics, Inc.(APGEcusip03770N101)	104.9K	QoQ +154.04% (+63.6K) YoY +1647.55% (+98.9K)	All Managers (Combined)	$3.9M	0.7% ($3.9M/$523.7M)	QoQ +109.51% (+$2.0M) YoY +882.52% (+$3.5M)
Savara Inc(SVRAcusip805111101)	1.4M	QoQ +37.61% (+371.8K) YoY +24190.91% (+1.4M)	All Managers (Combined)	$3.8M	0.7% ($3.8M/$523.7M)	QoQ +24.16% (+$733.4K) YoY +13411.20% (+$3.7M)
Monopar Therapeutics(MNPRcusip61023L207)	100.8K	QoQ -22.50% (-29.3K) YoY NEW(+100.8K)	All Managers (Combined)	$3.7M	0.7% ($3.7M/$523.7M)	QoQ +28.25% (-$808.4K) YoY NEW(+$3.7M)
(cusip008064107)✕	1.5M	QoQ +57.45% (+533.2K) YoY +9090.15% (+1.4M)	All Managers (Combined)	$3.7M	0.7% ($3.7M/$523.7M)	QoQ +49.13% (+$1.2M) YoY +680.09% (+$3.2M)